Company Ascentage Pharma Group International
Equities
6855
KYG0519B1023
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.88 HKD | +1.71% | +7.84% | -34.51% |
25/04 | Ascentage Pharma to Present Four Studies at US Oncology Meet | MT |
09/04 | Ascentage Pharma Chairman Boosts Stake in Firm | MT |
Business Summary
Number of employees: 583
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
87.2
%
| 203 | 83.4 % | 214 | 87.2 % | +5.13% |
License
11.7
%
| 28 | 11.6 % | 29 | 11.7 % | +1.62% |
Service
1.1
%
| 12 | 5.0 % | 3 | 1.1 % | -78.12% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 244 | 100.0 % | 245 | 100.0 % | +0.59% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Da Jan Yang
CEO | Chief Executive Officer | 61 | 01/09/01 |
Ming Guo
FOU | Founder | 67 | 01/09/01 |
Yi Qing Chen
DFI | Director of Finance/CFO | 40 | 29/21/29 |
Yifan Zhai
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/13/01 |
Gang Zhu
PRN | Corporate Officer/Principal | - | 04/20/04 |
Corporate Officer/Principal | - | 01/19/01 | |
Cheung Ki Wong
SEC | Corporate Secretary | 41 | 30/18/30 |
Thomas Knapp
LAW | General Counsel | 71 | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | 31/21/31 |
Shao Meng Wang
BRD | Director/Board Member | 60 | 17/17/17 |
Zheng Yin
BRD | Director/Board Member | 52 | 13/19/13 |
Chang Qing Ye
BRD | Director/Board Member | 53 | 01/19/01 |
Da Jan Yang
CEO | Chief Executive Officer | 61 | 01/09/01 |
Wei Ren
BRD | Director/Board Member | 43 | 13/19/13 |
Simon Dazhong Lu
BRD | Director/Board Member | 55 | 06/18/06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 290,212,060 | 212,890,469 ( 73.36 %) | 0 | 73.36 % |
Company contact information
Ascentage Pharma Group International Co., Ltd.
Suzhou Industrial Park 68 Xinqing Road
215000, Suzhou
+86 512 8555 7777
http://www.ascentage.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.51% | 651M | |
-3.46% | 102B | |
+1.41% | 96.09B | |
+2.13% | 22.28B | |
-15.84% | 21.4B | |
-10.21% | 18.14B | |
-39.98% | 17.02B | |
-14.65% | 16.09B | |
+4.39% | 13.83B | |
+31.35% | 11.97B |
- Stock Market
- Equities
- 6855 Stock
- Company Ascentage Pharma Group International